We are live on
!
Find out more
Celularity
CELU
CELU
32 hedge funds and large institutions have $3.85M invested in Celularity in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
276% more call options, than puts
Call options by funds: $188K | Put options by funds: $50K
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
34% more capital invested
Capital invested by funds: $2.86M → $3.85M (+$983K)
19% more funds holding
Funds holding: 27 → 32 (+5)
3.84% more ownership
Funds ownership: 4.39% → 8.23% (+3.8%)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
32
Holders Change
+5
Holders Change %
+18.52%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
8
Increased
4
Reduced
7
Closed
3
Calls
$188K
Puts
$50K
Net Calls
+$138K
Net Calls Change
-$81K
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$107K |
| 2 |
State Street
Boston,
Massachusetts
|
+$92.6K |
| 3 |
BFO
Biltmore Family Office
Charlotte,
North Carolina
|
+$83.5K |
| 4 |
CAM
CenterStar Asset Management
Chicago,
Illinois
|
+$52.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$39.6K |
Top Sellers
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$104K |
| 2 |
Renaissance Technologies
New York
|
-$29.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.73K |
